All posts by: Michael Zand

About Michael Zand

Scientists discover surprising immune cell activity that may be limiting immunotherapy – Medical Xpress

Continue reading

2017-10-30 NEWS

Medical Xpress

Scientists discover surprising immune cell activity that may be limiting immunotherapy
Medical Xpress
Cancer immunotherapy treatments work by supercharging the immune system to fight cancer. So when Tregs come in and suppress the immune response, it shuts down the cancer-fighting effect. But eliminating the Tregs doesn’t help. Researchers have tried …

and more »

Continue reading

2017-10-30 NEWS

Endpoints News

Sanofi Genzyme retreats from its Parkinson’s deal with gene therapy upstart Voyager, part of an $845M pact
Endpoints News
Sanofi $SNY gambled $100 million upfront in early 2015 on the hot gene therapy field, promising Voyager up to $745 million in milestones for their partnership on a full slate of development programs, capped by the leading Parkinson’s effort. Voyager
Voyager Therapeutics Announces Update to Parkinson’s Disease ProgramMarkets Insider

all 3 news articles »

Continue reading

2017-10-30 NEWS

Greenville Health System performs 1000th stem cell transplant
Spartanburg Herald Journal
Greenville Health System’s Cancer Institute marked its 1,000th stem cell transplant this month, marking a major milestone in 25 years of providing new transplant therapies in the Upstate, the healthcare system announced. Gwen King, 70, a retired